Michel Guiguet

886 total citations
25 papers, 628 citations indexed

About

Michel Guiguet is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Michel Guiguet has authored 25 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Michel Guiguet's work include Multiple Myeloma Research and Treatments (5 papers), Complement system in diseases (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Michel Guiguet is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Complement system in diseases (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Michel Guiguet collaborates with scholars based in France. Michel Guiguet's co-authors include Patrick Hillon, Jean‐Michel Petit, Anne Minello, Bruno Vergès, Jean-Marcel Brun, Jean‐Baptiste Bour, Olivier Casasnovas, Denis Caillot, Éric Solary and P. Chavanet and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Biochemistry and The Journal of Infectious Diseases.

In The Last Decade

Michel Guiguet

25 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Guiguet France 10 221 189 130 119 118 25 628
Giuseppe Aimo Italy 16 204 0.9× 98 0.5× 108 0.8× 80 0.7× 92 0.8× 44 749
Makoto Sueishi Japan 18 190 0.9× 73 0.4× 106 0.8× 97 0.8× 223 1.9× 50 1.0k
Fabrizio Scatena Italy 17 154 0.7× 107 0.6× 80 0.6× 50 0.4× 122 1.0× 35 632
Ansamma Joseph United States 15 106 0.5× 190 1.0× 184 1.4× 48 0.4× 268 2.3× 23 831
Haruyuki Shirasawa Japan 17 177 0.8× 80 0.4× 131 1.0× 41 0.3× 344 2.9× 45 804
A. Christopher Stevens United States 11 231 1.0× 138 0.7× 133 1.0× 71 0.6× 111 0.9× 13 789
Dolores Subirá Spain 15 178 0.8× 105 0.6× 116 0.9× 107 0.9× 144 1.2× 40 860
Akihiko Ohno Japan 18 290 1.3× 548 2.9× 96 0.7× 97 0.8× 216 1.8× 41 963
Agnieszka Adamek Poland 12 217 1.0× 185 1.0× 107 0.8× 51 0.4× 305 2.6× 33 767
Hirohiko ABE Japan 15 331 1.5× 280 1.5× 57 0.4× 150 1.3× 104 0.9× 70 829

Countries citing papers authored by Michel Guiguet

Since Specialization
Citations

This map shows the geographic impact of Michel Guiguet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Guiguet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Guiguet more than expected).

Fields of papers citing papers by Michel Guiguet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Guiguet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Guiguet. The network helps show where Michel Guiguet may publish in the future.

Co-authorship network of co-authors of Michel Guiguet

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Guiguet. A scholar is included among the top collaborators of Michel Guiguet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Guiguet. Michel Guiguet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amoura, Z., Michel Guiguet, L. Musset, et al.. (2008). Le pronostic du syndrome des antisynthétases est aux poumons. La Revue de Médecine Interne. 29. S31–S31. 1 indexed citations
2.
Clermont, Gaëlle, Stéphanie Lemaire‐Ewing, Catherine Vergely, et al.. (2007). In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress. Journal of Cardiovascular Pharmacology. 49(1). 39–45. 30 indexed citations
3.
Casasnovas, Olivier, Nicolas Mounier, Pauline Brice, et al.. (2007). Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology. 25(13). 1732–1740. 82 indexed citations
5.
Meynard, J.‐L., Michel Guiguet, A. Rachline, et al.. (2001). Facteurs prédictifs de réponse virologique à un traitement antirétroviral avec inhibiteur de protéase au cours de l'infection à VIH. La Presse Médicale. 30(1). 5–10. 1 indexed citations
6.
Petit, Jean‐Michel, Jean‐Baptiste Bour, Anne Minello, et al.. (2001). Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. Journal of Hepatology. 35(2). 279–283. 213 indexed citations
7.
Isnard, F, Michel Guiguet, Patricia Zunic, et al.. (2001). Improved efficiency of remission induction facilitates autologous BMT harvesting and improves overall survival in adults with AML: 108 patients treated at a single institution. Bone Marrow Transplantation. 27(10). 1045–1052. 5 indexed citations
8.
Guiguet, Michel, et al.. (1997). Misinterpretation of the Biological Activity of Cytokine-Containing Preparations Attributable to Unrecognized Interacting Components. Analytical Biochemistry. 247(2). 441–442. 2 indexed citations
9.
Guiguet, Michel, S. Prévot, Vincent Bertrand, et al.. (1997). Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation. British Journal of Cancer. 75(4). 528–536. 33 indexed citations
10.
Barbut, Frédéric, et al.. (1997). [Central venous catheters. Prospective surveillance of a hospital].. PubMed. 26(14). 656–62. 2 indexed citations
12.
Duvillard, Laurence, Michel Guiguet, Olivier Casasnovas, et al.. (1995). Diagnostic value of serum IL‐6 level in monoclonal gammopathies. British Journal of Haematology. 89(2). 243–249. 29 indexed citations
13.
Guiguet, Michel, et al.. (1995). Human interleukin-6 acts as a co-factor for the up-regulation of C3 production by rat liver epithelial cells.. PubMed. 5(4). 405–10. 5 indexed citations
14.
Pfitzenmeyer, Pierre, et al.. (1995). Les gammapathies monoclonales de signification indéterminée chez le sujet âgé: à propos de 80 cas. La Revue de Médecine Interne. 16(6). 399–404. 3 indexed citations
15.
Chavanet, P., Bernard Bonnotte, Michel Guiguet, et al.. (1992). High Concentrations of Intrathecal Interleukin-6 in Human Bacterial and Nonbacterial Meningitis. The Journal of Infectious Diseases. 166(2). 428–431. 56 indexed citations
16.
Solary, Éric, Michel Guiguet, Olivier Casasnovas, et al.. (1992). Radioimmunoassay for the measurement of serum IL‐6 and its correlation with tumour cell mass parameters in multiple myeloma. American Journal of Hematology. 39(3). 163–171. 56 indexed citations
17.
Guiguet, Michel, et al.. (1987). Third component of rat complement. Journal of Immunological Methods. 96(2). 157–164. 5 indexed citations
18.
Guiguet, Michel, et al.. (1987). Biosynthesis of the third component of complement in rat liver epithelial cell lines and its stimulation by effector molecules from cultured human mononuclear cells. In Vitro Cellular & Developmental Biology - Plant. 23(12). 821–829. 7 indexed citations
19.
Ronot, Xavier, C. Hecquet, Patrick Jaffray, et al.. (1983). Proliferation kinetics of rabbit articular chondrocytes in primary culture and at the first passage.. PubMed. 16(6). 531–7. 22 indexed citations
20.
Bournot, Paulette, J Desgrès, Michel Guiguet, et al.. (1975). Long term cell culture of rat liver epithelial cells retaining some hepatic functions. Biochimie. 56(10). 1365–1379. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026